Next Generation Immunotherapy
CD Biopharma is at the forefront of developing drugs through precisely calibrating immune system, with best-in-class and/ first-in-class potential, in our relentless pursuit of immunotherapies.
CD Biopharma leverages its proprietary Bispecific Fusion Protein (BsFP) platform and IMmune-Enhanced (IME) cell technology for advanced cell modification, driving groundbreaking research and clinical outcomes. Initial clinical data has been gathered from a couple of Investigator-Initiated Trials (IITs).
Company Details
- Founded
- -
- Address
- No. 689 Binhe Road, Suzhou,jiangsu,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Suzhou, Jiangsu
Cd Biopharma Questions
Cd Biopharma's website is https://www.cdbiopharma.com/en_index.html
Cd Biopharma's LinkedIn profile is https://cn.linkedin.com/company/cd-biopharma
Cd Biopharma's industry is
Biotechnology Research
Cd Biopharma's top competitors are
Mersana Therapeutics,
Cytokinetics,
Adcendo,
Degron Therapeutics,
Shockwave Medical,
Fiery,
Sciwind Biosciences,
Vibrant Therapeutics.
Cd Biopharma's categories are Biotechnology Research
Cd Biopharma's founding year is 2021
